<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antihypertensives | Pharmacology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Links populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-09-cardiovascular.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Previous</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">10</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">16</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 62%;"></div>
                            </div>
                            <span class="progress-label">Antihypertensives</span>
                        </div>
                        
                        <a href="topic-11-cns-depressants.html" class="nav-button nav-button--next" aria-label="Next section">
                            <span class="nav-text">Next</span>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Antihypertensives</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üìâ</span>
                        <span class="badge-text">Unit 10</span>
                    </div>
                    <h1 class="document-title">Antihypertensive Drugs</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üìÑ</span>
                            <span>Pages 69-74</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">‚è±Ô∏è</span>
                            <span>20 min read</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content -->
                <div class="content-wrapper">
                    <!-- START: antihypertensive-classes -->
                    <section id="antihypertensive-classes" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">Classes of Antihypertensive Drugs</h2>
                        </div>
                        <p>Single drug should be considered from the following classes:</p>
                        <ol class="enhanced-list">
                            <li class="list-item"><span class="list-marker">1</span><span class="list-content">Diuretics.</span></li>
                            <li class="list-item"><span class="list-marker">2</span><span class="list-content">Beta-blocking agents.</span></li>
                            <li class="list-item"><span class="list-marker">3</span><span class="list-content">Calcium channel blocking agents.</span></li>
                            <li class="list-item"><span class="list-marker">4</span><span class="list-content">Angiotesin converting enzyme inhibitors.</span></li>
                        </ol>
                        <p>‚ùñInitial therapy is continued for one month. If there is no response, combination therapy is needed.</p>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>Determine base line blood pressure before starting antihypertensive treatment.</li>
                                    <li>Evaluate the extent of the client‚Äôs understanding of the disease and the therapy.</li>
                                    <li>Ascertain lifestyle changes.</li>
                                    <li>Determine client‚Äôs ability to take his BP measurement.</li>
                                    <li>Record significant changes in BP readings.</li>
                                    <li>Advise client to adhere to low sodium diet.</li>
                                    <li>Explain the importance of adhering to treatments plan.</li>
                                    <li>Teach the patient/family how to measure intake and output.</li>
                                </ol>
                            </div>
                        </aside>
                    </section>
                    <!-- END: antihypertensive-classes -->

                    <!-- START: ace-inhibitors -->
                    <section id="ace-inhibitors" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">1. Angiotensin-converting enzyme inhibitors</h2>
                        </div>

                        <div class="content-card">
                            <h3>‚ùñCaptopril:</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content"><strong>Trade name:</strong> Capotin, nhabace.</span></li>
                                <li class="list-item"><span class="list-marker">‚ñ™</span><span class="list-content"><strong>Class:</strong> antihypertensive, inhibitor of angiotensin synthesis.</span></li>
                            </ul>

                            <h4>‚ñ™Action:</h4>
                            <ul>
                                <li>captopril is a highly specific competitive inhibitor of angiotensin I converting enzyme. The enzyme is responsible for the conversion of angiotensin I to angiotensin II which decrease BP.</li>
                                <li>reduce peripheral arterial resistance.</li>
                                <li>Decrease aldosterone secretion which works to increase level of serum potassium.</li>
                            </ul>

                            <h4>‚ñ™Indications:</h4>
                            <ol>
                                <li>Hypertension.</li>
                                <li>In combination with diuretics and digitalis in the treatment of CHF.</li>
                            </ol>

                            <p><strong>‚ñ™Contraindication:</strong> Hypersensitivity, renovascular disease and pregnancy.</p>

                            <p><strong>‚ñ™Side effects:</strong>Skin rash, loss of taste, neutropnea, nausea, vomiting, hypotension, proteinuria, renal failure and hyperkalemia.</p>

                            <h4>‚ñ™Dosage:</h4>
                            <p><strong>‚ñ™Tablets:</strong> - 12.5 mg 2-3 time per day.</p>
                            <p>- If there is no response, after 1-2 weeks, increase dose to 25 mg 2-3 time per day.</p>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>In case of overdose, give normal saline to restore BP.</li>
                                    <li>Should not be discontinued without Dr. order.</li>
                                    <li>Obtain baseline hematological studies, liver & renal functions tests prior to beginning the treatment.</li>
                                    <li>Determine client‚Äôs understanding of the therapy and if he/she takes other medications.</li>
                                    <li>Observe client closely for hypotension 3 hours after the initial dose.</li>
                                    <li>In case of hypotension, place client in supine position and give IV saline infusion.</li>
                                    <li>Withhold potassium sparing diuretics and consult with physician (hyperkalemia may occur).</li>
                                    <li>Take captopril 1 hour before meal or on an empty stomach.</li>
                                    <li>Report skin rash, heartburn, and chest pain to physician.</li>
                                    <li>Explain to client that he may develop loss of taste for 2-3 months, if it persist, notify the physician.</li>
                                </ol>
                            </div>
                        </aside>
                    </section>
                    <!-- END: ace-inhibitors -->

                    <!-- START: beta-blockers -->
                    <section id="beta-blockers" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">2. Beta-adrenargic blocking agents</h2>
                        </div>

                        <div class="content-card">
                            <p><strong>- Action:</strong> it combines with beta-adrenargic receptors to block the response to sympathetic nerve impulses, circulating catecholamines or adrenargic drugs.</p>
                            <p>- Œ≤-adrenergic receptors have been classified as beta 1 (in the cardiac muscle) and beta 2 (in the bronchi and blood vessels).</p>
                            <ul>
                                <li><strong>Blocking of Œ≤1 receptors</strong> HR, myocardial contractility and cardiac output BP.</li>
                                <li><strong>Blocking of Œ≤2 receptors</strong> airway resistance (bronchospasm), and vasoconstriction.</li>
                            </ul>
                            <p>- These drugs could be selective (working on one receptor such as Œ≤1 selective drugs (Atenolol) or it could be nonselective (such as Propranolol)</p>
                        </div>

                        <div class="table-wrapper">
                            <div class="table-container">
                                <table class="content-table">
                                    <tbody>
                                        <tr>
                                            <td><strong>Uses:</strong> 1. hypertension,</td>
                                            <td>2. Anginal pectoris.</td>
                                        </tr>
                                        <tr>
                                            <td>3. Cardiac arrhythmias.</td>
                                            <td>4. Myocardial infarction.</td>
                                        </tr>
                                        <tr>
                                            <td colspan="2">5. Prophylaxis of migrin.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                        </div>

                        <div class="callout callout--danger">
                            <div class="callout-header"><span class="callout-icon">üö´</span><span class="callout-title">Contraindications & Side Effects</span></div>
                            <div class="callout-content">
                                <p><strong>Contraindications:</strong> Bradycardia, C.H.F., cardiogenic shock, diabetes, thyrotoxicosis, chronic bronchitis, asthma, bronchospasm, emphysema.</p>
                                <p><strong>Side effects:</strong> Bradycardia, C.H.F., hypotension, cold extremities (due to peripheral vasoconstriction), edema, dyspnia, shortness of breath, nausea, vomiting, hepatomegaly and bronchospasm.</p>
                            </div>
                        </div>

                        <div class="content-card">
                            <h4>Treating overdose:</h4>
                            <ol class="enhanced-list">
                                <li class="list-item"><span class="list-marker">1</span><span class="list-content">Inducing vomiting, gastric lavage.</span></li>
                                <li class="list-item"><span class="list-marker">2</span><span class="list-content">Artificial respiration.</span></li>
                                <li class="list-item"><span class="list-marker">3</span><span class="list-content">Give atropine sulfate 0.6 mg (up to 3 mg) and glycogan for the treatment of bradycardia.</span></li>
                                <li class="list-item"><span class="list-marker">4</span><span class="list-content">Treat hypoglycemia and hypokalemia.</span></li>
                                <li class="list-item"><span class="list-marker">5</span><span class="list-content">I.V fluids.</span></li>
                                <li class="list-item"><span class="list-marker">6</span><span class="list-content">Adrenaline or dopamine to increase Blood pressure.</span></li>
                            </ol>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>Instruct patient/family to take blood pressure and pulse.</li>
                                    <li>Provide written instructions as when to call physician (e.g. HR below 50 beat/min).</li>
                                    <li>Consult the physician before interrupting the therapy.</li>
                                    <li>Some drugs lead to blurring of vision, so that tell patients not to engage in activities need mental alertness.</li>
                                    <li>Instruct patient to dress warmly during cold weather.</li>
                                    <li>Diabetic patient should be very careful about symptoms of hypoglycemia.</li>
                                    <li>Report any asthma-like symptoms.</li>
                                </ol>
                            </div>
                        </aside>

                        <h3>Examples:</h3>
                        <div class="content-card">
                            <h4>Atenolol:</h4>
                            <p><strong>Trade name:</strong> Normatin.</p>
                            <p><strong>Classification:</strong> Beta-adrenergic blocking agent</p>
                            <p><strong>Classification:</strong> beta 1 ‚Äìadrenoreceptr blocking drug which is a cardioselective.</p>
                            <div class="table-wrapper">
                                <table class="content-table">
                                    <tbody>
                                        <tr>
                                            <td><strong>Uses:</strong> Hypertension</td>
                                            <td>angina pectoris.</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>
                            <p><strong>Dosage:</strong></p>
                            <p><strong>Tablets:</strong> 50 mg or 100 mg daily</p>
                            <p>Initial dose is 50 mg, if there is no response, increase dose to 100 mg daily.</p>
                            <p>IV in case of acute MI: give 5 mg over 5 minutes, and if there is no response, give another 5 mg after 10 minutes.</p>
                            <p><strong>Specific nursing considerations:</strong></p>
                            <p>3. For IV use, the drug may be diluted in sodium chloride, dextrose, on dextrose saline.</p>
                        </div>

                        <div class="content-card">
                            <h4>Propranolol hydrochloride</h4>
                            <p><strong>Trade name:</strong> Inderal, Deralin</p>
                            <p><strong>Classification:</strong> beta-adrenergic blacking agent, antiarryhthmic.</p>
                            <p><strong>Action:</strong> manifests both beta1 and beta 2 adrenergic blocking activity.</p>
                            <p><strong>Indication:</strong></p>
                            <ol>
                                <li>Angina pectoris. 2. Hypertension.</li>
                                <li>Cardiac arrhytmias. 4. Prophylaxis of migrin.</li>
                                <li>Prophylaxis of MI. 6. Pheochromocytoma</li>
                            </ol>
                            <p><strong>Additional side effects:</strong> psoriasis-like eruptions.</p>
                            <p><strong>Dosage:</strong></p>
                            <p>Tablets: initial dose of 40 mg bid, then 120-240 mg in 2-3 divided doses.</p>
                            <p><strong>Contraindications:</strong> Asthma.</p>
                        </div>
                    </section>
                    <!-- END: beta-blockers -->

                    <!-- START: centrally-acting -->
                    <section id="centrally-acting" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">3. Centrally acting agents</h2>
                        </div>

                        <div class="content-card">
                            <h3>Methyldopa:</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Trade name:</strong> (Aldomin )</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Classification:</strong> Antihypertensive, centrally acting antiadrenergic agent.</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Action:</strong> The active metabolite alphamethylenorepinephrin lowers BP by stimulating central inhibitory alpha-adrenergic receptors.</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Uses:-</strong> Hypertension & hypertension crises (parenteral).</span></li>
                            </ul>

                            <h4>-Contraindications:-</h4>
                            <ol>
                                <li>Hypersensitivity,</li>
                                <li>Active hepatic diseases.</li>
                                <li>Pheochromocytoma.</li>
                            </ol>

                            <h4>-Side effects:-</h4>
                            <ul>
                                <li>Headache, dizziness, general weakness, depression and sedation.</li>
                                <li>Bradycardia, orthostatic hypotension.</li>
                                <li>Dry mouth, nausea, vomiting, sore (black) tongue.</li>
                                <li>Jaundice, liver disorders.</li>
                                <li>Hemolytic anemia, & leukopenea.</li>
                                <li>Male impotence.</li>
                            </ul>

                            <p><strong>- Dosage:</strong> Tabs. : initially 250 mg bid or tid.</p>
                        </div>

                        <aside class="callout callout--info">
                            <div class="callout-header"><span class="callout-icon">üë©‚Äç‚öïÔ∏è</span><span class="callout-title">Nursing considerations:</span></div>
                            <div class="callout-content">
                                <ol>
                                    <li>Avoid activities that need mental awareness such as driving.</li>
                                    <li>Note any evidence of jaundice and do liver function test on intervals.</li>
                                    <li>Advise pt. to rise from the bed slowly.</li>
                                    <li>Instruct pt. about reportable Signs & Symptoms</li>
                                    <li>Explain to pt. that urine rarely may be turn into dark / blue color.</li>
                                    <li>Advise client to carry a card detailing current medication regimens always.</li>
                                </ol>
                            </div>
                        </aside>
                    </section>
                    <!-- END: centrally-acting -->

                    <!-- START: vascular-smooth-muscle -->
                    <section id="vascular-smooth-muscle" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">5. Agents that act directly on vascular smooth muscles</h2>
                        </div>

                        <div class="content-card">
                            <h3>Hydralazine hydrochloride:-</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Trade name:-</strong> ( Apresoline )</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Classification:-</strong> Antihypertensive, direct action on vascular smooth muscles.</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Action:</strong> directly affect smooth muscles vasodilation, cardiac output and finally blood flow to the brain and kidneys.</span></li>
                                <li class="list-item"><span class="list-marker">-</span><span class="list-content"><strong>Uses:</strong> used with combination therapy to treat hypertension. Given parenterally in hypertension emergencies.</span></li>
                            </ul>

                            <h4>- Contraindications:</h4>
                            <ul>
                                <li>Angina pectoris.</li>
                                <li>Rheumatic heart disease.</li>
                                <li>Chronic glomerulonephritis.</li>
                                <li>Systemic lupupus erthrmatosis (S.L.E.)</li>
                            </ul>

                            <h4>- Side effects:-</h4>
                            <ul>
                                <li>Orthostatic hypotension, tachycardia, nausea, vomiting.</li>
                                <li>Headache, dizziness, constipation and male impotence.</li>
                            </ul>

                            <h4>- Dosage:-</h4>
                            <ul>
                                <li><strong>Tabs. :</strong> initially 10 mg qid for 2-4 days, then 25 mg bid</li>
                                <li><strong>I.V, I.M:</strong> 50 mg (IV slowly) repeated as necessary. (may decrease Bp in 5 minutes.)</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: vascular-smooth-muscle -->

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-09-cardiovascular.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Cardiovascular Drugs</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="topic-11-cns-depressants.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Next</span>
                                <span class="nav-title">CNS Depressants & Anticonvulsants</span>
                            </div>
                            <span class="nav-icon">‚Üí</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>